K J Gregor - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Clinical Therapeutics|May 1, 1996

Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitorsK J Gregor, J A Riley, D K Downing

Journal of Affective Disorders|December 5, 1997

Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?K J Gregor, K Way, C H Young, et al.

Clinical Therapeutics|March 1, 1994

Selective serotonin reuptake inhibitor dose titration in the naturalistic settingK J Gregor, J M Overhage, S J Coons, et al.

Pharmacotherapy|December 17, 1998

Concomitant therapy with anxiolytics or hypnotics and maintenance of initial SSRI therapyS A Shields, K J Gregor, C H Young, et al.

L'Encephale|November 5, 1999

[Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France]C Le Pen, H Lilliu, M P Allicar, et al.

Clinical Therapeutics|June 27, 2000

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con OlanzapinaJ A Sacristán, J C Gómez, A L Montejo, et al.

Clinical Therapeutics|September 16, 1998

Selective serotonin reuptake inhibitor utilization patterns: consistency across research designsD S Hutchins, E G Klein, W F Signa, et al.

Acta Psychiatrica Scandinavica|February 13, 2003

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitmentJ M Haro, E T Edgell, P B Jones, et al.

The American Journal of Managed Care|July 6, 1998

Outpatient antidepressant utilization in a Dutch sick fundK J Gregor, T R Hylan, P C van Dijk, et al.

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1996

The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparisonA E Copfer, N M Ampel, T E Hughes, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Clinical Therapeutics|May 1, 1996

Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitorsK J Gregor, J A Riley, D K Downing

Journal of Affective Disorders|December 5, 1997

Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?K J Gregor, K Way, C H Young, et al.

Clinical Therapeutics|March 1, 1994

Selective serotonin reuptake inhibitor dose titration in the naturalistic settingK J Gregor, J M Overhage, S J Coons, et al.

Pharmacotherapy|December 17, 1998

Concomitant therapy with anxiolytics or hypnotics and maintenance of initial SSRI therapyS A Shields, K J Gregor, C H Young, et al.

L'Encephale|November 5, 1999

[Economic comparison of olanzapine versus haloperidol in treatment of schizophrenia in France]C Le Pen, H Lilliu, M P Allicar, et al.

Clinical Therapeutics|June 27, 2000

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con OlanzapinaJ A Sacristán, J C Gómez, A L Montejo, et al.

Clinical Therapeutics|September 16, 1998

Selective serotonin reuptake inhibitor utilization patterns: consistency across research designsD S Hutchins, E G Klein, W F Signa, et al.

Acta Psychiatrica Scandinavica|February 13, 2003

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitmentJ M Haro, E T Edgell, P B Jones, et al.

The American Journal of Managed Care|July 6, 1998

Outpatient antidepressant utilization in a Dutch sick fundK J Gregor, T R Hylan, P C van Dijk, et al.

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1996

The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparisonA E Copfer, N M Ampel, T E Hughes, et al.

Pageof 1